Exploration of Actinobacteria for Multifaceted Applications: Lessons to Learn from the Genome, Proteome and Metabolome of Pristine Microbial Majority

PDF Review History

Published: 2024-04-19

Page: 172-184

Sankar Lokesh

Department of Microbiology, Sacred Heart College (Autonomous), Affiliated to Thiruvalluvar University, Tirupattur District, Tamil Nadu, India.

Natarajan Dinesh

Department of Microbiology, Sacred Heart College (Autonomous), Affiliated to Thiruvalluvar University, Tirupattur District, Tamil Nadu, India.

R. Thamarai Selvi

Department of Microbiology, Sacred Heart College (Autonomous), Affiliated to Thiruvalluvar University, Tirupattur District, Tamil Nadu, India.

Sasikumar Pavithra

Department of Microbiology, Sacred Heart College (Autonomous), Affiliated to Thiruvalluvar University, Tirupattur District, Tamil Nadu, India.

Pazhani Saranraj

Department of Microbiology, Sacred Heart College (Autonomous), Affiliated to Thiruvalluvar University, Tirupattur District, Tamil Nadu, India.

Karuppiah Vijay *

Department of Microbiology, Sacred Heart College (Autonomous), Affiliated to Thiruvalluvar University, Tirupattur District, Tamil Nadu, India.

*Author to whom correspondence should be addressed.


Actinobacteria are a diverse group of bacteria known for their prolific production of bioactive secondary metabolites. These metabolites have garnered significant attention in recent years due to their wide-ranging potential for biomedical applications. This review aims to provide an overview of actinobacterial metabolites and their significance in various aspects of biomedical research and applications. Actinobacterial metabolites are known for their diverse chemical structures and biological activities. They encompass a wide array of compounds, including antibiotics, anticancer agents, immunomodulators, and enzyme inhibitors. These metabolites have been instrumental in the development of numerous pharmaceuticals that have transformed the field of medicine. In the context of antibacterial research, actinobacterial metabolites have played a pivotal role in combating multidrug-resistant pathogens. Their potent antimicrobial properties have led to the discovery of antibiotics such as streptomycin, vancomycin, and rifamycin, which have been crucial in treating bacterial infections. This review highlights the diverse biomedical applications of actinobacterial metabolites, emphasizing their role in combating infectious diseases, cancer, drug discovery, and immunotherapy. The exploration of actinobacterial biodiversity and their metabolite diversity holds great promise for addressing current and emerging biomedical challenges. Furthermore, advancements in genomics, synthetic biology, and bioprocessing techniques are expected to enhance the production and utilization of actinobacterial metabolites for future biomedical innovations. Moreover, actinobacterial metabolites have shown potential in immunomodulation, opening avenues for the development of immunotherapies and vaccines. Compounds like teicoplanin and tacrolimus have been employed to modulate the immune system and treat autoimmune diseases and organ transplantation.

Keywords: Actinobacteria, antibiotics, anticancer agents, immunomodulation, biomedical applications, secondary metabolites

How to Cite

Lokesh, S., Dinesh , N., Selvi , R. T., Pavithra , S., Saranraj , P., & Vijay , K. (2024). Exploration of Actinobacteria for Multifaceted Applications: Lessons to Learn from the Genome, Proteome and Metabolome of Pristine Microbial Majority. Asian Journal of Research in Biosciences, 6(2), 172–184. Retrieved from https://globalpresshub.com/index.php/AJORIB/article/view/2017


Download data is not yet available.


Alvarez A, Saez JM, Costa JS, Colin VL, Fuentes MS, Cuozzo SA, et al. Actinobacteria: current research and perspectives for bioremediation of pesticides and heavy metals. Chemosphere. 2017;166:41-62.

Cycoń M, Mrozik A, Piotrowska-Seget Z. Bioaugmentation as a strategy for the remediation of pesticide-polluted soil: A review. Chemosphere. 2017;172:52-71.

Zhang X, Ren K, Zhang L. Screening and preliminary identification of medicinal plants endophytic actinobacteria used for inhibiting penicillin-resistant Staphylococcus aureus. Int J Biol. 2012;4(2):119–124.

El-Shatoury S, Abdulla H, El-Karaaly O, El-Kazzaz W, Dewedar A. Bioactivities of endophytic actinobacteria from selected medicinal plants in the world heritage site of Saint Katherine. Egypt Int J Bot. 2006;2(3):307–312.

Tanvir R, Sajid I, Hasnain S. Larvicidal potential of Asteraceae family endophytic actinobacteria against Culex quinquefasciatus mosquito larvae. Nat Prod Res. 2014;28(22):2048–2052.

Zhou H, Yang Y, Zhang J, Peng T, Zhao L, Xu L, et al. Alkaloids from an endophytic Streptomyces sp. YIM66017. Nat Prod Commun. 2013;8(10):1393–1396.

Taechowisan T, Wanbanjob A, Tuntiwachwuttikul P, Taylor WC. Identification of Streptomyces sp. Tc022, an endophyte in Alpinia galanga, and the isolation of actinomycin D. Ann Microbiol. 2006;56:113–117.

Anandan R, Dharumadurai D, Manogaran GP. An introduction to actinobacteria. In: Actinobacteria-basics and biotechnological applications. IntechOpen. 2016.

Shankar PR, Balasubramanium R. Antimicrobial resistance: global report on surveillance 2014. Australasian Medical Journal (Online). 2014;7(5):237.

Ho CH, Böhm S, Monciardini D. The collaborative and contested interplay between business and civil society in circular economy transitions. Business Strategy and the Environment. 2022;31(6):2714-2727.

Norouzi H, Danesh A, Mohseni M, Khorasgani MR. Marine Actinobacteria with Probiotic Potential and Bioactivity against Multidrugdrug-Resistant Bacteria. Int J Mol Cell Med. 2018;7:44.

Joo GJ. Production of an antifungal substance for biological control of Phytophthora capsici causing phytophthora blight in red-peppers by Streptomyces halstedii. Biotechnol Lett. 2005;27(3):201–5.

Errakhi R, Bouteau F, Lebrihi A, Barakate M. Evidences of biological control capacities of Streptomyces spp. against Sclerotium rolfsii responsible for damping-off disease in sugar beet (Beta vulgaris L.). World Journal of Microbiology and Biotechnology. 2007;23:1503-1509.

Fourati-Ben Fguira L, Fotso S, Ben Ameur-Mehdi R, Mellouli L, Laatsch H. Purification and structure elucidation of antifungal and antibacterial activities of newly isolated Streptomyces sp strain US80. Res Microbiol. 2005;156(3):341–7.

Mukherjee G, Sen SK. Purification, characterization and antifungal activity of chitinase from Streptomyces venezuelae P10. Curr Microbiol. 2006;53(4):265–9.

El-Tarabily KA, Soliman MH, Nassar AH, Al-Hassani HA, Sivasithamparam K, McKenna F, et al. Biological control of Sclerotinia minor using a chitinolytic bacterium and actinobacteria. Plant Pathol. 2000;49(5):573–83.

Hayakaa M, Yamamura H, Nakagawa Y, Kawa Y, Hayashi Y, Misonou T, et al. Taxonomic diversity of Actinobacteria Isolated from Swine Manure Compost. Actinomycetologica. 2010;24:58–62.

Vijay K, Sree KK, Devi TS, Soundarapandian S, Ramasamy V, Thangavel K. Computational biology approaches revealing novel target in vascular wilt pathogen Fusarium oxysporum f. sp. lycopersici for the ligands of marine actinobacterial origin. J Pure Appl Microbiol. 2020;14(1):363-373.

Devi TS, Vijay K, Vidhyavathi RM, Kumar P, Govarthanan M, Kavitha T. Antifungal activity and molecular docking of phenol, 2, 4-bis (1, 1-dimethylethyl) produced by plant growth-promoting actinobacterium Kutzneria sp. strain TSII from mangrove sediments. Archives of microbiology. 2021;203:4051-4064.

Abdelmohsen UR, Bayer K, Hentschel U. Diversity, abundance and natural products of marine sponge-associated actinobacteria. Natural product reports. 2014;31(3):381-399.

Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8:623–633.

Cui J, Ren B, Tong Y, et al. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans. Virulence. 2015;6(4):362-371.

Ambavane V, Tokdar P, Parab R, et al. Caerulomycin A—an antifungal compound isolated from marine actinobacteria. Adv in Microbiol. 2014;4(9):567-578.

Asnani A, Ryandini D, Suwandri. Screening of marine actinobacteria from Segara Anakan for natural pigment and hydrolytic activities. IOP Conf Ser Mat Sci Eng. 2016;107:012056.

Sanglard D. Emerging threats in antifungal-resistant fungal pathogens. Front Med (Lausanne). 2016;3:11.

Tingwei Z, Chenxian Y, Xuerui B, Fusheng C, Xingfeng G. Strategies for controlling biofilm formation in food industry. Grain Oil Sci Technol; 2022. Available:https://doi.org/10.1016/j.gaost.2022.06.003.

Cai W, Arias CR. Biofilm formation on aquaculture substrates by selected bacterial fish pathogens. J Aquat Anim Health. 2017;29:95–104.

Flemming HC, Neu TR, Wozniak DJ. The EPS matrix: the “house of biofilm cells”. J Bacteriol. 2007;189:7945–7947.

Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future medicinal chemistry. 2015;7(4):493-512.

Roy R, Tiwari M, Donelli G, Tiwari V. Strategies for combatingbacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018;9(1):522-554.

Oberoi JK, Momin T, Ande R, Katkar N. Inhibition of bacterial biofilms by Streptomyces derived crude extract. J Biol Today’s World. 2020;9:211.

Cheng YB, Jensen PR, Fenical W. Cytotoxic and Antimicrobial Napyradiomycins from Two Marine-Derived Streptomyces Strains. Eur J Organ Chem. 2013;3751–3757. doi: 10.1002/ejoc.201300349.

ELnahas M, Elkhateeb W, Daba G. Marine actinobacteria the past, the present and the future. Pharm Res. 2021;5:000241.

Magin CM, Cooper SP, Brennan AB. Non-toxic antifouling strategies. Mater Today. 2010;13:36–44. doi: 10.1016/S1369-7021(10)70058-4.

Conrad JC, Poling-Skutvik R. Confined Flow: Consequences and Implications for Bacteria and Biofilms. Annu Rev Chem Biomol Eng. 2018;9:175–200. DOI: 10.1146/annurev-chembioeng-060817-084006.

Piola RF, Johnston EL. The potential for translocation of marine species via small-scale disruptions to antifouling surfaces. Biofouling. 2008;24:145–155. DOI: 10.1080/08927010801930480.

Butnariu M, Grozea I. Antioxidant (Antiradical) Compounds. Bioequivalence and Bioavailability. J Bioequiv Availab. 2012:4(6).

Prieto P, Pineda M, Aguilar M. Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: Specific application to the determination of vitamin E. Analytical Biochemistry. 1999:269;337-41.

Khalaf NA, Shakya AK, Othman A, Agbar Z, Farah H. Antioxidant activity of some common plants. Turk J Biol. 2008:32;51-5.

Cedillo-Peláez C, Rico-Torres CP, Salas-Garrido CG, Correa D. Acute toxoplasmosis in squirrel monkeys (Saimiri sciureus) in Mexico. Veterinary parasitology. 2011;180(3-4):368-371.

Bhatnagar SK, Kim SK. Pharmacologically prospective antibiotic agents and their sources: a marine microbial perspective. Environ Toxicol Pharmacol. 2012;34:631-643.

Qasim SZ. Some unique characteristics of the Indian Ocean. 1999.

Fenical W, Jensen PR. Developing a new resource for drug discovery: marine actinomycete bacteria. Nat Chem Biol. 2006;2(12):666-673.

Akarolo-Anthony SN, Ogundiran TO, Adebamowo CA. Emerging breast cancer epidemic: evidence from Africa. Breast Cancer Res. 2010;12:1-4.

Ravikumar S, Gnanadesigan M, Thajuddin N, Chakkaravarthi VSD, Banerjee BM. Anticancer property of sponge associated actinobacteria along Palk strait. J Pharm Res. 2010;3(10):2415–2417.

Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular Aspects of Medicine. 2006;27(1):1–93.

Langseth L. Oxidants, antioxidants, and disease prevention. Brussels, Belgium: ILSI Europe; 1995.

Arcamone F, Cassinelli G, Fantini G, Grein A, Orezzi P, Pol C, et al. Adriamycin, 14-hydroxydaimomycin, a new antitumor antibiotic from S. peucetius var. caesius. Biotechnol Bioeng. 1969;11:1101–1110.

Lin Y, Chen Y, Ukaji T, Okada S, Umezawa K. Isolation of ketomycin from Actinobacteria as an inhibitor of 2D and 3D cancer cell invasion. J Antibiot. 2018;72:148–154.

Rai MM, Rathod MK, Padole A, Khurad AM. Mosquitoes menace to humanity. In: William SJ, editor. Defeating the Public Enemy, the Mosquito: A Real Challenge. Loyola Publications; 2007. pp. 398-403.

WHO (World Health Organization). Global Malaria Programme. Geneva: WHO; 2013.

Borah R, Kalita MC, Kar A, Talukdar AK. Larvicidal efficacy of Toddalia asiatica (Linn.) Lam against two mosquito vector Aedes aegypti and Culex quinquefasciatus. African Journal of Biotechnology. 2010;9:2527-2530.

Rahuman AA, Bagavan A, Kamaraj C, Saravanan E, Zahir AA, Elango G. Efficacy of the larvicidal botanical extracts against Culex quinquefasciatus Say (Dipetera: Culicidae). Parasitology Research. 2009;104:1365-1372.

Reegan AD, Kumar PS, Asharaja AC, Devi C, Jameela S, Balakrishna K, et al., Larvicidal and ovicidal activities of phenyl acetic acid isolated from Streptomyces collinus against Culex quinquefasciatus Say and Aedes aegypti L.(Diptera: Culicidae). Experimental Parasitology. 2021;2021:108120.

World Health Organization. The World Health Report 1996: Fighting Disease, Fostering Development. Geneva: WHO. 1996;48.

Paulraj MG, Kumar PS, Ignacimuthu S, Sukumaran D. Natural insecticides from actinobacteria and other microbes for vector mosquito control. Herbal Insecticides, Repellents and Biomedicines: Effectiveness and Commercialization. 2016;85-99.

Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005;434:214-217.

Li X, Jing T, Zhou D, Zhang M, Qi D, Zang X, Zhao Y, Li K, Tang W, Chen Y, et al., Biocontrol efficacy and possible mechanism of Streptomyces sp. H4 against postharvest anthracnose caused by Colletotrichum fragariae on strawberry fruit. Postharvest Biol. Technol. 2021; 175:111401.

DOI: 10.1016/j.postharvbio.2020.111401.

Zou N, Zhou D, Chen Y, Lin P, Chen Y, Wang W, Xie J, Wang M. A novel antifungal actinomycete Streptomyces sp. strain H3-2 effectively controls banana Fusarium wilt. Front. Microbiol. 2021; 12:706647.

DOI: 10.3389/fmicb.2021.706647.

Tiwari K, Gupta RK. Diversity and isolation of rare actinobacteria: An overview. Crit. Rev. Microbiol. 2013;39:256–294. DOI: 10.3109/1040841X.2012.709819.

Ascencion LC, Liang WJ, Yen TB. Control of Rhizoctonia solani damping-off disease after soil amendment with dry tissues of Brassica results from increase in Actinobacteria population. Biological Control. 2015;82:21-30.

Javoreková S, Kovácsová S, Medo J, Maková J, Petrová J, Hleba L, Košťálová D, Cinkocki R. Soil amended with organic fertilizers as a source of actinobacteria with high potential as biocontrol agents. J. Microbiol. Biotechnol. Food Sci. 2021; 8:1352–1359. DOI: 10.15414/jmbfs.2019.8.6.1352-1359.

Lahlali R, Ezrari S, Radouane N, Kenfaoui J, Esmaeel Q, El Hamss H, Belabess Z, Ait Barka E. Biological control of plant pathogens: A global perspective. Microorganisms. 2022;10:596.

DOI: 10.3390/microorganisms10030596.

Kaari M, Joseph J, Manikkam R, Sreenivasan A, Venugopal G, Alexander B, Krishnan S. Anti-Biofilm activity and biocontrol potential of streptomyces cultures against Ralstonia solanacearum on tomato plants. Indian J. Microbiol. 2022;62:32–39. DOI: 10.1007/s12088-021-00963-1.

Ma HM, Zhou Q, Tang YM, Zhang Z, Chen YS, He HY, Tang GL. Unconventional origin and hybrid system for construction of pyrrolopyrrole moiety in kosinostatin biosynthesis. Chemistry & Biology. 2013;20(6):796-805.

Tohyama S, Kakinuma K, Eguchi T. The complete biosynthetic gene cluster of the 28-membered polyketide macrolactones, halstoctacosanolides, from Streptomyces halstedii HC34. The Journal of Antibiotics. 2006;59(1):44-52.

Singh SB, Genilloud O, Peláez F. Terrestrial Microorganisms – Filamentous Bacteria. Comprehensive Natural Products II. Elsevier. 2010;109-140.

Feldman D, Vander Els N. Bleomycin-induced lung injury. UpToDate. Wolters Kluwer; 2017.

Richter TK, Hughes CC, Moore BS. Sioxanthin, a novel glycosylated carotenoid, reveals an unusual subclustered biosynthetic pathway. Environ Microbiol. 2015;17(6):2158-2171.

Aamir M, Rai KK, Zehra A, Dubey MK, Samal S, Yadav M, et al. Endophytic actinobacteria in bioactive compounds production and plant defense system. In: Microbial Endophytes. Kumar A, Singh VK, eds. Woodhead Publishing. 2020;189–229.

Lobo CB, Tomás MSJ, Viruel E, Ferrero MA, Lucca ME. Development of low-cost formulations of plant growth-promoting bacteria to be used as inoculants in beneficial agricultural technologies. Microbiol Res. 2019;219:12–25.

Souza RD, Ambrosini A, Passaglia LM. Plant growth-promoting bacteria as inoculants in agricultural soils. Gen Mol Biol. 2015;38:401–19.

Santi C, Bogusz D, Franche C. Biological nitrogen fixation in non-legume plants. Annals of Botany. 2013;111(5):743-767.

Kim J, Rees DC. Nitrogenase and biological nitrogen fixation. Biochemistry. 1994;33(2):389-397.

Benson DR, Silvester W. Biology of Frankia strains, actinomycete symbionts of actinorhizal plants. Microbiology and Molecular Biology Reviews. 1993;57(2):293-319.

Saharan BS, Nehra V. Plant growth promoting rhizobacteria: a critical review. Life Sci Med Res. 2011;21(1):30.